This event was previously reported to the fda on an alternative summary report (asr approval #: e2013038) which is no longer in effect.Because of additionally received complaint information, this and all further updates will be submitted through the 3500a form.Concomitant medical products: system t-sling with centrasorb¿.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of stress incontinence, symptomatic cystocele and rectocele.It was reported that after implant, the patient experienced post-op blood loss requiring transfusion of two units of blood, small area of heterogenous fluid collection in left sidewall, foreign body in the genitourinary tract, pelvic pain, dyspareunia, urge incontinence, urinary frequency, frequent urinary tract infections, urinary stream abnormality, stress incontinence.Post-operative patient treatment included surgical intervention.The device had been used with avaulta¿ anterior biosynthetic support system t-sling with centrasorb¿.
|